Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Yann Vano"'
Autor:
Laurence Albiges, Bernard Escudier, Catherine Sautes-Fridman, Benoit Beuselinck, Lydie Cassard, Maxime Meylan, Nathalie Rioux-Leclercq, Aude Desnoyer, Guillaume Lacroix, Nathalie Chaput-Gras, Marie Naigeon, Lisa Boselli, Salem Chouaib, Lucia Carril-Ajuria, Cécile Dalban, Yann Vano, Sylvie Chabaud, Janice Barros-Monteiro, Antoine Bougoüin, Irelka Colina-Moreno, Florence Tantot, Caroline De Oliveira, Wolf Herve Fridman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Background The phase II NIVOREN GETUG-AFU 26 study reported safety and efficacy of nivolumab in patients with metastatic clear cell renal cell carcinoma (m-ccRCC) in a ‘real-world setting’. We conducted a translational-research program to determi
Externí odkaz:
https://doaj.org/article/3b8448255849403eaa7f2df395db9ee2
Autor:
Xiaofan Lu, Yann Vano, Alexandra Helleux, Xiaoping Su, Véronique Lindner, Guillaume Davidson, Roger Mouawad, Jean-Philippe Spano, Morgan Rouprêt, Reza Elaidi, Eva Compérat, Virginie Verkarre, Chengming Sun, Christine Chevreau, Mostefa Bennamoun, Hervé Lang, Thibault Tricard, Wenxuan Cheng, Li Xu, Irwin Davidson, Fangrong Yan, Wolf Herman Fridman, Catherine Sautes-Fridman, Stéphane Oudard, Gabriel G. Malouf
Publikováno v:
Clinical Cancer Research. 29:1279-1291
Purpose: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of patients with clear-cell renal cell carcinomas (ccRCC). Although analyses of transcriptome, genetic alterations, and the tumor microenvironment (TME) have shed light int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e11c3eb95ae69ab3ce70e784a420aa
https://doi.org/10.1158/1078-0432.ccr-22-2133
https://doi.org/10.1158/1078-0432.ccr-22-2133
Autor:
Antonio Farina, Cristina Birzu, Mad-Helenie Elsensohn, Alberto Picca, Sergio Muñiz-Castrillo, Alberto Vogrig, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, Luca Massacesi, Baptiste Hervier, Sarah Guégan, Nora Kramkimel, Yann Vano, Joe Elie Salem, Yves Allenbach, Thierry Maisonobe, Souad Assaad, Aurélien Maureille, Perrine Devic, Nicolas Weiss, Antoine Pegat, Delphine Maucort-Boulch, Damien Ricard, Jérôme Honnorat, Dimitri Psimaras, Bastien Joubert
Publikováno v:
Brain Communications.
While the spectrum of neurological immune checkpoint inhibitor-related adverse events is expanding, patients’ outcomes are not well documented. This study aimed to assess outcomes of neurological immune-related adverse events and to identify progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa15a2e5be96e91285f58bf3d6f1e132
https://doi.org/10.1093/braincomms/fcad169
https://doi.org/10.1093/braincomms/fcad169
Autor:
Gabriel G. Malouf, Stéphane Oudard, Catherine Sautes-Fridman, Wolf Herman Fridman, Fangrong Yan, Irwin Davidson, Li Xu, Wenxuan Cheng, Thibault Tricard, Hervé Lang, Mostefa Bennamoun, Christine Chevreau, Chengming Sun, Virginie Verkarre, Eva Compérat, Reza Elaidi, Morgan Rouprêt, Jean-Philippe Spano, Roger Mouawad, Guillaume Davidson, Véronique Lindner, Xiaoping Su, Alexandra Helleux, Yann Vano, Xiaofan Lu
Purpose:Immune checkpoint inhibitors (ICI) have revolutionized the treatment of patients with clear-cell renal cell carcinomas (ccRCC). Although analyses of transcriptome, genetic alterations, and the tumor microenvironment (TME) have shed light into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d565608e16d885770979fdf98b23e457
https://doi.org/10.1158/1078-0432.c.6532839
https://doi.org/10.1158/1078-0432.c.6532839
Autor:
Gabriel G. Malouf, Stéphane Oudard, Catherine Sautes-Fridman, Wolf Herman Fridman, Fangrong Yan, Irwin Davidson, Li Xu, Wenxuan Cheng, Thibault Tricard, Hervé Lang, Mostefa Bennamoun, Christine Chevreau, Chengming Sun, Virginie Verkarre, Eva Compérat, Reza Elaidi, Morgan Rouprêt, Jean-Philippe Spano, Roger Mouawad, Guillaume Davidson, Véronique Lindner, Xiaoping Su, Alexandra Helleux, Yann Vano, Xiaofan Lu
Figure S2. Focal copy number deletion identified by the GISTIC algorithm for a) 𝑇𝐸𝐷+ and b) 𝑇𝐸𝐷−, respectively, in the TCGA-KIRC cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31fcf5cf8adfb56e1748fafb0760265b
https://doi.org/10.1158/1078-0432.22494933
https://doi.org/10.1158/1078-0432.22494933
Autor:
Gabriel G. Malouf, Stéphane Oudard, Catherine Sautes-Fridman, Wolf Herman Fridman, Fangrong Yan, Irwin Davidson, Li Xu, Wenxuan Cheng, Thibault Tricard, Hervé Lang, Mostefa Bennamoun, Christine Chevreau, Chengming Sun, Virginie Verkarre, Eva Compérat, Reza Elaidi, Morgan Rouprêt, Jean-Philippe Spano, Roger Mouawad, Guillaume Davidson, Véronique Lindner, Xiaoping Su, Alexandra Helleux, Yann Vano, Xiaofan Lu
Supplementary Tables S1-S23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68ff291fc643ecd8eeabdb1d73045e5
https://doi.org/10.1158/1078-0432.22488930
https://doi.org/10.1158/1078-0432.22488930
Autor:
Catherine Sautès-Fridman, Wolf H. Fridman, Xavier Cathelineau, Claire Germain, Sarah Bourass, Benedicte Buttard, Audrey Moatti, Stephane Oudard, Alexandre Ingels, Rafael Sanchez-Salas, Pierre Validire, Laetitia Lacroix, Florent Petitprez, Yann Vano, Etienne Becht, Nicolas A. Giraldo
Purpose: The efficacy of PD-1 checkpoint blockade as adjuvant therapy in localized clear cell renal cell carcinoma (ccRCC) is currently unknown. The identification of tumor microenvironment (TME) prognostic biomarkers in this setting may help define
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75bfdff03ef6e0cdeacab6c93b421371
https://doi.org/10.1158/1078-0432.c.6526922.v1
https://doi.org/10.1158/1078-0432.c.6526922.v1
Autor:
Catherine Sautès-Fridman, Wolf H. Fridman, Stephane Oudard, Marie-Caroline Dieu-Nosjean, Gordon J. Freeman, Frederic Triebel, Aurelie Cazes, Diane Damotte, Marco Alifano, Audrey Lupo, Ivo Natario, Laetitia Lacroix, Nicolas Saint-Aubert, Arnaud Mejean, Yann Vano, Virginie Verkarre, Georgios Skliris, Franck Pagès, Etienne Becht, Nicolas A. Giraldo
Table S1. Demographic and clinical characteristics of the analyzed patients are depicted (Mean {plus minus} SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ab5cedba06f8195a06309d6da1d428
https://doi.org/10.1158/1078-0432.22457627
https://doi.org/10.1158/1078-0432.22457627
Autor:
Catherine Sautès-Fridman, Wolf H. Fridman, Stephane Oudard, Marie-Caroline Dieu-Nosjean, Gordon J. Freeman, Frederic Triebel, Aurelie Cazes, Diane Damotte, Marco Alifano, Audrey Lupo, Ivo Natario, Laetitia Lacroix, Nicolas Saint-Aubert, Arnaud Mejean, Yann Vano, Virginie Verkarre, Georgios Skliris, Franck Pagès, Etienne Becht, Nicolas A. Giraldo
Figure S4. Inverse relation between TLS and immune checkpoints in primary ccRCC : photomicrographs of immunohistochemistry staining of PD-L1(red)/hematoxylin and TLS structures as revealed by CD3(Blue)DC-Lamp(Red), CD21(Blue)/CD20(Red), and of CD8(re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb1a950c55edb7faca7dad1d3068e2c8
https://doi.org/10.1158/1078-0432.22457630.v1
https://doi.org/10.1158/1078-0432.22457630.v1
Autor:
Catherine Sautès-Fridman, Wolf H. Fridman, Xavier Cathelineau, Claire Germain, Sarah Bourass, Benedicte Buttard, Audrey Moatti, Stephane Oudard, Alexandre Ingels, Rafael Sanchez-Salas, Pierre Validire, Laetitia Lacroix, Florent Petitprez, Yann Vano, Etienne Becht, Nicolas A. Giraldo
Table S1. Demographic and clinical characteristics of the analyzed patients; Table S2. Antibodies and conditions used for the IHC studies; Table S3. List of immune-related genes analyzed by Low Density Array; Figure S1. Gating and data analysis strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154a9059b10773872b215ef046eb6296
https://doi.org/10.1158/1078-0432.22468394
https://doi.org/10.1158/1078-0432.22468394